These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29124745)

  • 1. Medication Access in America and Medicare Part D: Prescription Shopping Saves but May Be Costly.
    Upchurch G; Disco ME; Visco JL; Huffman KF
    J Am Geriatr Soc; 2018 Jan; 66(1):33-40. PubMed ID: 29124745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of generic competition and benefit management practices on spending for prescription drugs: evidence from Medicare's Part D benefit.
    Sheingold S; Nguyen NX
    Medicare Medicaid Res Rev; 2014; 4(1):. PubMed ID: 24918023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis.
    Li DG; Najafzadeh M; Kesselheim AS; Mostaghimi A
    BMJ; 2019 Jul; 366():l4257. PubMed ID: 31315833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare part D after 2 years.
    Joyce GF; Goldman DP; Vogt WB; Sun E; Jena AB
    Am J Manag Care; 2009 Aug; 15(8):536-44. PubMed ID: 19670957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in drug coverage generosity and untreated serious mental illness: transitioning from Medicaid to Medicare Part D.
    Madden JM; Adams AS; LeCates RF; Ross-Degnan D; Zhang F; Huskamp HA; Gilden DM; Soumerai SB
    JAMA Psychiatry; 2015 Feb; 72(2):179-88. PubMed ID: 25588123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why France Spends Less Than the United States on Drugs: A Comparative Study of Drug Pricing and Pricing Regulation.
    Raimond VC; Feldman WB; Rome BN; Kesselheim AS
    Milbank Q; 2021 Mar; 99(1):240-272. PubMed ID: 33751664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act.
    Myerson R; Qato DM; Goldman DP; Romley JA
    JAMA; 2023 Aug; 330(7):660-662. PubMed ID: 37486673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should drug prices be negotiated under part D of Medicare? And if so, how?
    Frank RG; Newhouse JP
    Health Aff (Millwood); 2008; 27(1):33-43. PubMed ID: 18180478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adequacy of Prescription Drug Coverage in Long-term Care.
    Briesacher B; Oliveri-Mui B; Chhabra B; Koethe B
    Med Care; 2020 May; 58(5):427-432. PubMed ID: 31985585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse selection in the Medicare prescription drug program.
    Riley GF; Levy JM; Montgomery MA
    Health Aff (Millwood); 2009; 28(6):1826-37. PubMed ID: 19887424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Medicare Part D drug plans--results from a roundtable discussion.
    Balfour DC; Evans S; Januska J; Lee HY; Lewis SJ; Nolan SR; Noga M; Stemple C; Thapar K
    J Manag Care Pharm; 2009; 15(1 Suppl A):18-21. PubMed ID: 19125557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in Medicare Part D risk adjustment: beneficiary access and payment accuracy.
    Kautter J; Ingber M; Pope GC; Freeman S
    Med Care; 2012 Dec; 50(12):1102-8. PubMed ID: 22922436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.
    Briesacher BA; Ross-Degnan D; Wagner AK; Fouayzi H; Zhang F; Gurwitz JH; Soumerai SB
    Med Care; 2010 Jun; 48(6):503-9. PubMed ID: 20473197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Between Medicare Part D and Out-of-Pocket Spending, HIV Viral Load, Adherence, and ADAP Use in Dual Eligibles With HIV.
    Belenky N; Pence BW; Cole SR; Dusetzina SB; Edmonds A; Oberlander J; Plankey MW; Adedimeji A; Wilson TE; Cohen J; Cohen MH; Milam JE; Golub ET; Adimora AA
    Med Care; 2018 Jan; 56(1):47-53. PubMed ID: 29227443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending.
    Dusetzina SB; Conti RM; Yu NL; Bach PB
    JAMA Intern Med; 2017 Aug; 177(8):1185-1188. PubMed ID: 28558108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis.
    Tseng CW; Dudley RA; Chen R; Walensky RP
    JAMA Netw Open; 2020 Apr; 3(4):e202739. PubMed ID: 32286656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.
    Yazdany J; Dudley RA; Chen R; Lin GA; Tseng CW
    Arthritis Rheumatol; 2015 Jun; 67(6):1474-80. PubMed ID: 25900105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors.
    Neuman P; Strollo MK; Guterman S; Rogers WH; Li A; Rodday AM; Safran DG
    Health Aff (Millwood); 2007; 26(5):w630-43. PubMed ID: 17711865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.